{"name":"Vivacelle Bio","slug":"vivacelle-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNNGxGcHlFZkpLUDlxMFhSSkRNUWM5eDRXM0pUMlg3cXBsUHdIOGRXZk5kemZKSUZfLTlmWnB0Y1k0bnlOdHlDTk4wcHg1SGxRalBEbk5tNG1pWVpYeDZ6Wk1kVkRGZ3dNTWI0N1p5WTRVYnRzakVROHMzSkp4aVJ4c01yUG9ya2tpX2N1c09mNkxCY2NvNVRfLXRaVGN5SHJuQm5HdkNoSHlFRTRPRlJOSU1nUFFMZ1Z4c0EycEhLd3phSVd3cUFXNG1nOHQxbTZnWWJrR0MyV1lRZzhDY1dMYWRfMFZYYzJGX01wQw?oc=5","date":"2024-12-04","type":"deal","source":"prnewswire.com","summary":"2Flo Ventures Welcomes Esteemed Pharmaceutical Executive Rodney Cotton, MBA, MSSM as a Venture Partner - prnewswire.com","headline":"2Flo Ventures Welcomes Esteemed Pharmaceutical Executive Rodney Cotton, MBA, MSSM as a Venture Partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNOUhwbktTZmZvT3ZLWkdaeG9yd1Q5ZTZLWDBBbFhQV09FcE1ibjdGdnM1ZWZiMmUyVjE5RDFRVF9RcDZUT0tOTm1CLWF2Z21telRtb1R0QlE1Rml5dHpGekVwNF9td1pzTC0zMk9SSkZGYjg4YzVZbW9WMWxDM1lheW9ISFRBTmhCa0kwN1NTYjJHcHRQZzJ3ZmNGMk9tMV8zbkhlLVQ3dVNaZmV6UU16V2Rjaw?oc=5","date":"2024-07-23","type":"trial","source":"Pharmaceutical Executive","summary":"Vivacelle Bio Launches Phase III Clinical Trial for VBI-S to Treat Hypovolemic Septic Shock - Pharmaceutical Executive","headline":"Vivacelle Bio Launches Phase III Clinical Trial for VBI-S to Treat Hypovolemic Septic Shock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOVjBncmhrTTJ0eXZza1ljMnNzMkl5Y1BpcjliVU1JdHRrVWRMUjNDV1J5LS1adlM3SDNLRUlUYzJZRjJxVzFYODQ1bTFqVXkwVHNicjdoOU9iN25wSHlsdHdFeFRBOW5tcE9LQ2lKNFhla1BNdmlWbHM4WEJUTW9ZTlRaX2xYcmxoWm5zQy10WHREWHpoLVJ5Y3l3dGtSZ3hyVm5pQ21hN3JEQ1FIeTZIYWN3aHNlYllaWVVmaEowYTFyNWlmV1RQWldBUlZrdklpTFltS1hPQ3dZelNnOWhrUW5mVndoWFI2bW92bW84bl9FYmZrRGxRa3Bn?oc=5","date":"2024-06-02","type":"deal","source":"prnewswire.com","summary":"2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner - prnewswire.com","headline":"2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPelNuMGdtM05lN1h6X0xqZW9lSnZUSElTWWZUczdIaVctaG85LWx6UnVlOGZaWC1DRWNoWnVZWTBpX0xZU0hKTjRMYkl6aTg5dGoyY0h5aUlSYXN1SjhCd2IybnFkNk5kdk96Ukw1ZHJJbmFVcGg1cVdaUlB0Mko4aA?oc=5","date":"2023-06-29","type":"pipeline","source":"Yahoo Finance","summary":"Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Merck, Shionogi, Sentien Biotechnologies, Basilea, Vivacelle Bio, Sanofi, BioAegis","headline":"Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Me","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}